Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01694953 · ClinicalTrials.gov registry record
The Natural History Study of Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE)
A clinical trial of Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE), sponsored by Columbia University.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT01694953: Recruiting study of Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE), sponsored by Columbia University.
NCT01694953 is a study of Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE) that is actively recruiting participants, run by Columbia University. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01694953, a study of Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE), is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a multi-center natural history study of Mitochondrial NeurogastroIntestinal Encephalopathy (MNGIE). Patients will be followed over time to assess clinical symptoms. The investigators hope to learn more about the disease of MNGIE as well as develop useful measures of disease status for use in future clinical trials. Additional clinical centers will be listed as they become available.
Primary Outcome
The timed water swallow test evaluates the time it takes to swallow a small cup of water
Conditions Studied
Study Locations (1)
New York
- Columbia University - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-02 |
| Est. Completion | 2026-12 |
What NCT01694953 shows while recruiting
NCT01694953 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 1 condition, with Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE) appearing as the primary indexed condition, and to 0 interventions.
NCT01694953 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01694953 about?
NCT01694953 is a clinical study titled "The Natural History Study of Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE)". This is a multi-center natural history study of Mitochondrial NeurogastroIntestinal Encephalopathy (MNGIE). Patients will be followed over time to assess clinical symptoms. The investigators hope to learn more about the disease of MNGIE as well as develop useful measures of disease status for use in...
What is the current status of trial NCT01694953?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2013-02. Estimated completion is 2026-12.
What conditions does trial NCT01694953 study?
This clinical trial studies the following conditions: Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE).
Who is sponsoring clinical trial NCT01694953?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01694953 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia